American Heart Association/American College of Cardiology Foundation guide to warfarin therapy1 <FN ID="FN1"><NO>1</NO>The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.</FN>

Detalles Bibliográficos
Publicado en:Journal of the American College of Cardiology (JACC) Vol. 41; no. 9; pp. 1633 - 1653
Autores principales: Hirsh, Jack, Fuster, Valentin, Ansell, Jack, Halperin, Jonathan L.
Formato: practice guidelines Journal Article
Publicado: Elsevier B.V. May2003
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=9656946&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 9656946
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        07351097
        20P
      jtl: Journal of the American College of Cardiology (JACC)
      issn: 07351097
      maglogo: N
    pubinfo:
      dt: May2003
      vid: 41
      iid: 9
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        9656946
        9656946
        NLM12742309
        9656946
        10.1016/S0735-1097(03)00416-9
        NLM12742309
        9656946
      ppf: 1633
      ppct: 20
      formats:
      tig:
        atl: American Heart Association/American College of Cardiology Foundation guide to warfarin therapy1 <FN ID="FN1"><NO>1</NO>The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.</FN>
      aug:
        au:
          Hirsh, Jack
          Fuster, Valentin
          Ansell, Jack
          Halperin, Jonathan L.
      sug:
        subj:
          Warfarin Pharmacodynamics
          Anticoagulants Therapeutic Use
          Anticoagulants Pharmacodynamics
          Practice Guidelines Standards
          Cardiovascular Diseases Drug Therapy
          American Heart Association
          Medical Organizations Standards
          Warfarin Therapeutic Use
          Female
          Dose-Response Relationship, Drug
          United States
          Male
          Drug Administration Schedule
          Age Factors
          Anticoagulants Administration and Dosage
          Warfarin Administration and Dosage
          Pregnancy
          Female
          Male
      pubtype: Academic Journal
      doctype:
        practice guidelines
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N